Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
CEO Action Plan: 48-Hour Crisis Response to Undisclosed Liver Failure Risk Objective: Protect patient safety, uphold ethical and legal obligations, mitigate long-term reputational and financial damage, maintain regulatory trust, and safeguard employee morale—all while navigating immense pressure.Read the full answer